Neovascular age-related macular degeneration treated with ranibizumab or aflibercept in the same large clinical setting: visual outcome and number of injections
Annette Rasmussen, Birgit Sander, Michael Larsen, Sara Brandi, Josefine Fuchs, Louise H Hansen, Henrik Lund-Andersen
Dive into the research topics of 'Neovascular age-related macular degeneration treated with ranibizumab or aflibercept in the same large clinical setting: visual outcome and number of injections'. Together they form a unique fingerprint.